Global Liquid Biopsy Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	167 Pages	TechNavio	June, 2024	INF19006747

Best Price Guarantee
Price	from $2,500
Length	167 Pages
Publisher	TechNavio
Published Date	June, 2024
SKU	INF19006747

Global Liquid Biopsy Market 2024-2028

The liquid biopsy market is forecasted to grow by USD 3696.4 mn during 2023-2028, accelerating at a CAGR of 25.2% during the forecast period. The report on the liquid biopsy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of cancer, growing focus on personalized medicine for cancer care, and advancements in liquid biopsy technologies.

Technavio's liquid biopsy market is segmented as below:

ByApplication

Cancer applications
Non-cancer applications

ByTechnology

CTC and ctDNA
Exosome and RNA

ByGeography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing funding/investment for liquid biopsy as one of the prime reasons driving the liquid biopsy market growth during the next few years. Also, strategic partnerships among academic institutions, industries and M and A and emerging applications of liquid biopsy will lead to sizable demand in the market.

The report on the liquid biopsy market covers the following areas:

Liquid biopsy market sizing
Liquid biopsy market forecast
Liquid biopsy market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading liquid biopsy market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, ANGLE Plc, Bio Rad Laboratories Inc., Bio Techne Corp., Biocept Inc., Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corp., F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Inivata Ltd., MDXHEALTH SA, Mesa Laboratories Inc., Myriad Genetics Inc., Novogene Co. Ltd., OncoCyte Corp., QIAGEN NV, and SAGA Diagnostics AB. Also, the liquid biopsy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Market Segmentation by Technology; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Liquid Biopsy Market 2018 - 2022; Historic Market Size - Data Table on Global Liquid Biopsy Market 2018 - 2022 ($ million); 4.2 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.3 Technology segment analysis 2018 - 2022; Historic Market Size - Technology Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application: 6.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 6.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 6.3 Cancer applications - Market size and forecast 2023-2028; Chart on Cancer applications - Market size and forecast 2023-2028 ($ million); Data Table on Cancer applications - Market size and forecast 2023-2028 ($ million); Chart on Cancer applications - Year-over-year growth 2023-2028 (%); Data Table on Cancer applications - Year-over-year growth 2023-2028 (%); 6.4 Non-cancer applications - Market size and forecast 2023-2028; Chart on Non-cancer applications - Market size and forecast 2023-2028 ($ million); Data Table on Non-cancer applications - Market size and forecast 2023-2028 ($ million); Chart on Non-cancer applications - Year-over-year growth 2023-2028 (%); Data Table on Non-cancer applications - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by Technology: 7.1 Market segments; Chart on Technology - Market share 2023-2028 (%); Data Table on Technology - Market share 2023-2028 (%); 7.2 Comparison by Technology; Chart on Comparison by Technology; Data Table on Comparison by Technology; 7.3 CTC and ctDNA - Market size and forecast 2023-2028; Chart on CTC and ctDNA - Market size and forecast 2023-2028 ($ million); Data Table on CTC and ctDNA - Market size and forecast 2023-2028 ($ million); Chart on CTC and ctDNA - Year-over-year growth 2023-2028 (%); Data Table on CTC and ctDNA - Year-over-year growth 2023-2028 (%); 7.4 Exosome and RNA - Market size and forecast 2023-2028; Chart on Exosome and RNA - Market size and forecast 2023-2028 ($ million); Data Table on Exosome and RNA - Market size and forecast 2023-2028 ($ million); Chart on Exosome and RNA - Year-over-year growth 2023-2028 (%); Data Table on Exosome and RNA - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Technology; Market opportunity by Technology ($ million); Data Table on Market opportunity by Technology ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.11 Japan - Market size and forecast 2023-2028; Chart on Japan - Market size and forecast 2023-2028 ($ million); Data Table on Japan - Market size and forecast 2023-2028 ($ million); Chart on Japan - Year-over-year growth 2023-2028 (%); Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 A. Menarini Industrie Farmaceutiche Riunite Srl; A. Menarini Industrie Farmaceutiche Riunite Srl - Overview; A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service; A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings; 12.4 ANGLE Plc; ANGLE Plc - Overview; ANGLE Plc - Product / Service; ANGLE Plc - Key offerings; 12.5 Bio Techne Corp.; Bio Techne Corp. - Overview; Bio Techne Corp. - Business segments; Bio Techne Corp. - Key news; Bio Techne Corp. - Key offerings; Bio Techne Corp. - Segment focus; 12.6 Biocept Inc.; Biocept Inc. - Overview; Biocept Inc. - Product / Service; Biocept Inc. - Key offerings; 12.7 Biodesix Inc.; Biodesix Inc. - Overview; Biodesix Inc. - Product / Service; Biodesix Inc. - Key offerings; 12.8 CellMax Inc.; CellMax Inc. - Overview; CellMax Inc. - Product / Service; CellMax Inc. - Key offerings; 12.9 CIRCULOGENE; CIRCULOGENE - Overview; CIRCULOGENE - Product / Service; CIRCULOGENE - Key offerings; 12.10 Exact Sciences Corp.; Exact Sciences Corp. - Overview; Exact Sciences Corp. - Product / Service; Exact Sciences Corp. - Key news; Exact Sciences Corp. - Key offerings; 12.11 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.12 Guardant Health Inc.; Guardant Health Inc. - Overview; Guardant Health Inc. - Product / Service; Guardant Health Inc. - Key news; Guardant Health Inc. - Key offerings; 12.13 Illumina Inc.; Illumina Inc. - Overview; Illumina Inc. - Business segments; Illumina Inc. - Key news; Illumina Inc. - Key offerings; Illumina Inc. - Segment focus; 12.14 MDXHEALTH SA; MDXHEALTH SA - Overview; MDXHEALTH SA - Product / Service; MDXHEALTH SA - Key offerings; 12.15 Myriad Genetics Inc.; Myriad Genetics Inc. - Overview; Myriad Genetics Inc. - Product / Service; Myriad Genetics Inc. - Key news; Myriad Genetics Inc. - Key offerings; 12.16 QIAGEN NV; QIAGEN NV - Overview; QIAGEN NV - Product / Service; QIAGEN NV - Key news; QIAGEN NV - Key offerings; 12.17 SAGA Diagnostics AB; SAGA Diagnostics AB - Overview; SAGA Diagnostics AB - Product / Service; SAGA Diagnostics AB - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations

Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Market Segmentation by Technology; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Liquid Biopsy Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Technology Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Application - Market share 2023-2028 (%); Exhibits33: Data Table on Application - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Application; Exhibits35: Data Table on Comparison by Application; Exhibits36: Chart on Cancer applications - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Cancer applications - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Cancer applications - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Cancer applications - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Non-cancer applications - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Non-cancer applications - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Non-cancer applications - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Non-cancer applications - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Application ($ million); Exhibits45: Data Table on Market opportunity by Application ($ million); Exhibits46: Chart on Technology - Market share 2023-2028 (%); Exhibits47: Data Table on Technology - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Technology; Exhibits49: Data Table on Comparison by Technology; Exhibits50: Chart on CTC and ctDNA - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on CTC and ctDNA - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on CTC and ctDNA - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on CTC and ctDNA - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Exosome and RNA - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Exosome and RNA - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Exosome and RNA - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Exosome and RNA - Year-over-year growth 2023-2028 (%); Exhibits58: Market opportunity by Technology ($ million); Exhibits59: Data Table on Market opportunity by Technology ($ million); Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits63: Chart on Geographic comparison; Exhibits64: Data Table on Geographic comparison; Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Japan - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Japan - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits101: Market opportunity By Geographical Landscape ($ million); Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits103: Impact of drivers and challenges in 2023 and 2028; Exhibits104: Overview on criticality of inputs and factors of differentiation; Exhibits105: Overview on factors of disruption; Exhibits106: Impact of key risks on business; Exhibits107: Companies covered; Exhibits108: Matrix on companies position and classification; Exhibits109: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview; Exhibits110: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service; Exhibits111: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings; Exhibits112: ANGLE Plc - Overview; Exhibits113: ANGLE Plc - Product / Service; Exhibits114: ANGLE Plc - Key offerings; Exhibits115: Bio Techne Corp. - Overview; Exhibits116: Bio Techne Corp. - Business segments; Exhibits117: Bio Techne Corp. - Key news; Exhibits118: Bio Techne Corp. - Key offerings; Exhibits119: Bio Techne Corp. - Segment focus; Exhibits120: Biocept Inc. - Overview; Exhibits121: Biocept Inc. - Product / Service; Exhibits122: Biocept Inc. - Key offerings; Exhibits123: Biodesix Inc. - Overview; Exhibits124: Biodesix Inc. - Product / Service; Exhibits125: Biodesix Inc. - Key offerings; Exhibits126: CellMax Inc. - Overview; Exhibits127: CellMax Inc. - Product / Service; Exhibits128: CellMax Inc. - Key offerings; Exhibits129: CIRCULOGENE - Overview; Exhibits130: CIRCULOGENE - Product / Service; Exhibits131: CIRCULOGENE - Key offerings; Exhibits132: Exact Sciences Corp. - Overview; Exhibits133: Exact Sciences Corp. - Product / Service; Exhibits134: Exact Sciences Corp. - Key news; Exhibits135: Exact Sciences Corp. - Key offerings; Exhibits136: F. Hoffmann La Roche Ltd. - Overview; Exhibits137: F. Hoffmann La Roche Ltd. - Business segments; Exhibits138: F. Hoffmann La Roche Ltd. - Key news; Exhibits139: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits140: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits141: Guardant Health Inc. - Overview; Exhibits142: Guardant Health Inc. - Product / Service; Exhibits143: Guardant Health Inc. - Key news; Exhibits144: Guardant Health Inc. - Key offerings; Exhibits145: Illumina Inc. - Overview; Exhibits146: Illumina Inc. - Business segments; Exhibits147: Illumina Inc. - Key news; Exhibits148: Illumina Inc. - Key offerings; Exhibits149: Illumina Inc. - Segment focus; Exhibits150: MDXHEALTH SA - Overview; Exhibits151: MDXHEALTH SA - Product / Service; Exhibits152: MDXHEALTH SA - Key offerings; Exhibits153: Myriad Genetics Inc. - Overview; Exhibits154: Myriad Genetics Inc. - Product / Service; Exhibits155: Myriad Genetics Inc. - Key news; Exhibits156: Myriad Genetics Inc. - Key offerings; Exhibits157: QIAGEN NV - Overview; Exhibits158: QIAGEN NV - Product / Service; Exhibits159: QIAGEN NV - Key news; Exhibits160: QIAGEN NV - Key offerings; Exhibits161: SAGA Diagnostics AB - Overview; Exhibits162: SAGA Diagnostics AB - Product / Service; Exhibits163: SAGA Diagnostics AB - Key offerings; Exhibits164: Inclusions checklist; Exhibits165: Exclusions checklist; Exhibits166: Currency conversion rates for US$; Exhibits167: Research methodology; Exhibits168: Information sources; Exhibits169: Data validation; Exhibits170: Validation techniques employed for market sizing; Exhibits171: Data synthesis; Exhibits172: 360 degree market analysis; Exhibits173: List of abbreviations